FDA Approves New Interchangeable Biosimilar to Pertuzumab By Ogkologos - December 3, 2025 271 0 Facebook Twitter Google+ Pinterest WhatsApp Approval is based on comparisons across a broad range of structural and functional product quality attributes Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Survivors of Childhood Cancer are at Excess Risk of Late Mortality... April 21, 2023 8-Year-Old Cancer Survivor Celebrates Recovery By Donating Her Birthday Gifts To... July 23, 2019 How My Inherited Cancer Diagnosis Has Made Me a Better Oncologist February 23, 2021 Countdown to 100,000 OncoLife Survivorship Care Plans: What is a Survivorship... February 25, 2021 Load more HOT NEWS March is Multiple Myeloma Action Month Los obstáculos en la atención para las personas LGBTQ con cáncer:... After Struggling With Chronic Illnesses Most of Her Life, This Author... Police Officer Has Bulletproof Vest to Thank for Helping Her Discover...
